This page shows the latest emerging markets news and features for those working in and with pharma, biotech and healthcare.
3, Excellence in Collaboration and Partnerships. Sponsored by Sanofi Genzyme. Winner: AstraZeneca Emerging Markets Health Innovation Hubs: Reimagining Patient Experiences and Improving Health Outcomes Through Unique Collaborations by AstraZeneca.
This included offloading a number of its OTC and prescription medicines in emerging markets in Near East, Middle East and Africa (NEMEA) countries to Acino for $200m.
That’s an increase of 14% at a constant exchange rate, thanks mostly to sales increases in emerging markets including China.
Those indications helped the drug to deliver sales of $1.6bn in 2019, which constitutes a 23% growth over the year driven in particular by a strong performance in emerging markets.
Product sales were up 12% to $23.57bn for the full-year, driven by cancer products and turnover in emerging markets, although there was a bit of a slowdown to 8% ... Emerging market sales rose 18% to $2.09bn in the fourth quarter, accounting for a
His experience includes serving as president of MSD international and the company’s emerging markets unit, and he will be joined by Carrie Cox, ex-CEO of Humacyte, who will chair
More from news
Approximately 13 fully matching, plus 354 partially matching documents found.
As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast- growing emerging markets continue to rise.
The idea was to illustrate the growing importance of emerging economies relative to developed markets and to encourage the G7 to factor them into policymaking. ... He added: “The hype about BRIC markets is cooler than it used to be.
Developed and emerging markets differ greatly but there are also great differences between developed markets, such as Europe and the US. ... And within markets, therapy areas differ hugely, ranging from rare diseases and oncology to primary care and
Now the business has two particularly strong growth drivers: emerging markets, most especially China, and oncology, where a triumvirate of drugs – Tagrisso, Imfinzi and Lynparza – have hit a major growth phase. ... So does AstraZeneca believe there
the US market when they would, de facto, be barred from other developed and price-controlled markets. ... As emerging markets become richer, access to at least basic healthcare is one of the first developed market characteristics that their citizens seek
More from intelligence
Approximately 14 fully matching, plus 61 partially matching documents found.
Her more recent focus has been in conducting business in emerging markets. ... In the newly created global director role, Rees will focus on expanding the business across the company, as well as developing business opportunities in emerging markets.
regional head for US vaccines, vice president for emerging markets for primary care and vice president of the US brands business within essential health.
Hallberg, who joins from Takeda, where he served for seven years, first as senior director and corporate counsel and then more recently as its vice president, general counsel for emerging markets.
emerging markets.
Prior to joining Neovii he headed up Novartis’ emerging growth markets and institutional customers businesses.
More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.
China: How pharma can maximize success in this rapidly changing emerging market. ... Register for this live webinar in which Research Partnership's emerging market experts explore the recent 2020 healthcare reforms, digital transformations as a result of
Maximising digital communications with physicians in China. Research Partnership are currently conducting a syndicated study to assess the impact of COVID-19 on how Chinese doctors use digital channels to interact with pharma companies through
Healthcare under AMLO – One year on. In this article, Rachel Howard and local expert Dr Xavier Tello, discuss the latest changes in the healthcare system and consider what they mean for pharmaceutical manufacturers wishing to enter the Mexican
She has previously worked in a wide range of research industries including consumer and digital and has experience in many global markets, especially emerging markets, having lived and worked for a
All eyes on Spinraza. Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil? In April 2019, Brazilian Health Minister Luiz Henrique
More from PMHub
Approximately 68 fully matching, plus 39 partially matching documents found.
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...